CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
transcranial direct current stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02928848
NCT02928848N/ACompleted
CompareCT.gov

Baseline Performance Predicts tDCS-mediated Improvements in Language Symptoms in Primary Progressive Aphasia

University of Pennsylvania·interventional·Posted Oct 10, 2016·Updated Jun 3, 2021

In Brief

A clinical study evaluating transcranial direct current stimulation for Primary Progressive Aphasia. Completed, enrolled 16 participants across 1 site.

Detailed Summary

In the present sham-controlled study, the investigators examine whether tDCS could be used to enhance language abilities (e.g., picture naming) in individuals with primary progressive aphasia (PPA) primarily characterized by difficulties with speech production.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Progressive Aphasia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 10, 2016
Enrollment StartJun 16, 2017
Primary CompletionMar 10, 2020
Study CompletionMar 13, 2020
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 9.7 years ago

Interventions

transcranial direct current stimulationdevice

Transcranial direct current stimulation (tDCS) is a type of noninvasive brain stimulation that modulates the resting excitability of neuronal populations, thereby altering patterns of brain activity in potentially behaviorally relevant ways. The stimulation involves 20 minutes of constant stimulation at 1.5 mA.